This HTML5 document contains 153 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30878925
rdf:type
wikibase:Item
schema:description
2014年學術文章 artikulong pang-agham наукова стаття, опублікована в грудні 2014 научна статия vitskapeleg artikkel 2014년 논문 artículo científico publicado en 2014 videnskabelig artikel (udgivet 2014) 2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված บทความทางวิทยาศาสตร์ 2014年学术文章 2014年學術文章 mokslinis straipsnis 2014年學術文章 научни чланак επιστημονικό άρθρο 2014年学术文章 سائنسی مضمون научни чланак vitenskapelig artikkel tieteellinen artikkeli 2014 nî lūn-bûn articol științific 2014年學術文章 bilimsel makale научная статья wetenschappelijk artikel tudományos cikk 2014年学术文章 artigo científico artigo científico (publicado na 2014) artículu científicu espublizáu en 2014 2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel bài báo khoa học სამეცნიერო სტატია article científic мақолаи илмӣ scienca artikolo مقالهٔ علمی 2014年學術文章 article scientifique (publié 2014) 2014年学术文章 artikull shkencor artykuł naukowy scientific article мақолаи илмӣ article scientific naučni članak teaduslik artikkel 2014年の論文 2014年学术文章 vetenskaplig artikel مقالة علمية (نشرت في 15-12-2014) 2014年學術文章 מאמר מדעי ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek vedecký článok articolo scientifico artigo científico (publicado na 2014)
p:P577
wds:Q30878925-84097BAD-6213-4FFC-A2A3-5B25511CB2CD
wdt:P577
2014-12-15T00:00:00Z
p:P2860
wds:Q30878925-F4C09055-FD43-4E20-87DB-B8C29533A9BB wds:Q30878925-D68267A3-D6FD-4751-8E3F-F0968A5BD3D0 wds:Q30878925-DFED1853-DB0A-4AA7-9628-45F1F6413DF7 wds:Q30878925-21B23ACF-4A03-448F-AAE4-583DB16C35B5 wds:Q30878925-2CB0BB66-E442-4279-AA2D-595FBB3405CD wds:Q30878925-1D9E5828-286E-4420-AB1E-F27E6E1826CD wds:Q30878925-42E7BC07-D9D9-4E0B-833A-0EC19BF686C6 wds:Q30878925-83FA0C12-7CF1-4CF7-BC5E-829EAEFF42A3 wds:Q30878925-7CDE894E-7C42-499D-90CC-62001420BC7E wds:Q30878925-82A19690-AB72-45F0-A851-5B9D525588F9 wds:Q30878925-AECEDC2F-1D95-46E9-B6E5-2EC5CB4BA702 wds:Q30878925-8FEE3D92-1A14-4F2A-AB99-5DC5D870E701 wds:Q30878925-93B74683-7D50-4D55-AB21-01CBDC98FF4B wds:Q30878925-A064F88F-EC9C-4B7B-9459-0135C08EA051
wdt:P2860
wd:Q37590738 wd:Q38129971 wd:Q44187537 wd:Q34422206 wd:Q38046098 wd:Q39063102 wd:Q53036812 wd:Q37325001 wd:Q36166771 wd:Q27022482 wd:Q40723187 wd:Q24612084 wd:Q29616218 wd:Q34188723
p:P2093
wds:Q30878925-C247E545-AB97-48D5-B778-A39B4CA82B0B wds:Q30878925-5AF1941D-4775-4C14-B79D-31ADBC18A3D0 wds:Q30878925-6FA918E2-D78A-4DDA-8894-CF1A214FE83D wds:Q30878925-7348067E-9D0A-4E9A-AE67-00D357A4266C wds:Q30878925-61A4986E-1DA5-411B-8E57-C80526D79113 wds:Q30878925-301A2126-A00B-489D-B1F7-11B2AB3E2FF6
wdt:P2093
G Sonpavde M A Eisenberger R de Wit M Rosenthal F Mercier B Tombal
rdfs:label
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
skos:prefLabel
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
schema:name
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
p:P50
wds:Q30878925-0D08F4A9-BC89-4DE0-8984-C7EC7AA93107 wds:Q30878925-02EEF6CB-1B5F-4F83-8E66-858D011CF337 wds:Q30878925-A35096C5-A5BB-47A0-8DC1-B21DAF217AEF wds:Q30878925-D3D11426-D74C-45B6-844C-3785D9FD5D8F wds:Q30878925-59D5031A-341D-4B64-9E11-05F56AEAFC7E
wdt:P50
wd:Q106114426 wd:Q91787962 wd:Q106650854 wd:Q37841237 wd:Q56943978
p:P1476
wds:Q30878925-847E3962-395E-4D8F-B786-DDF0EB0F1DA7
wdt:P1476
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials
p:P304
wds:Q30878925-75E7FA7E-E02B-4388-A116-8540557FC009
wdt:P304
743-749
p:P31
wds:Q30878925-9111BD89-ADF3-4A3F-8DB2-915739C2306D
wdt:P31
wd:Q13442814
p:P921
wds:Q30878925-418A85E0-0981-4102-96F7-48B44A56C0A4 wds:Q30878925-5BF2EA10-0CCA-4198-A1B4-F4851AE051FE wds:Q30878925-EC314B75-4CE6-4088-A0E7-01C7D44115CF wds:Q30878925-EF2F11C6-CCD8-4601-B814-4E664BC57BBE wds:Q30878925-1F2B37E5-8FCC-4D6F-86D8-1C03BB90C0E2
wdt:P921
wd:Q715347 wd:Q974135 wd:Q181257 wd:Q864574 wd:Q42824827
p:P698
wds:Q30878925-7B7EF299-7BEC-4471-8A6F-2272B9D596BE
wdtn:P698
n8:25515657
wdt:P698
25515657
p:P1433
wds:Q30878925-1821DD16-4B5A-4EE0-8F38-6230234003F2
wdt:P1433
wd:Q326122
p:P433
wds:Q30878925-8F10246E-1804-491F-B469-38F85421F22C
p:P478
wds:Q30878925-E6812192-4490-4EC7-98DA-BCC3252F8ADE
wdt:P433
4
wdt:P478
26
p:P356
wds:Q30878925-D8909162-6786-4455-B342-32C07A331C77
wdtn:P356
n11:MDU569
wdt:P356
10.1093/ANNONC/MDU569
p:P8608
wds:Q30878925-16F01E13-DA4C-414B-990C-F892431D14B0
wdt:P8608
release_gwd4slvakjgkxhkvk3vy2cyovi